Neuronetics_logo-RGB purple.png
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting
June 09, 2021 08:00 ET | Neuronetics
MALVERN, Pa., June 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics to Present at The JMP Securities Life Sciences Conference
June 03, 2021 08:00 ET | Neuronetics
MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Names Todd Cushman as Vice President, Business Development
June 01, 2021 08:00 ET | Neuronetics
MALVERN, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference
May 20, 2021 08:00 ET | Neuronetics
MALVERN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center
May 17, 2021 08:00 ET | Neuronetics
MALVERN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Reports First Quarter 2021 Financial and Operating Results
May 04, 2021 07:00 ET | Neuronetics
MALVERN, Pa., May 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences
May 03, 2021 08:00 ET | Neuronetics
MALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting
April 29, 2021 08:00 ET | Neuronetics
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call
April 20, 2021 08:00 ET | Neuronetics
MALVERN, Pa., April 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
April 14, 2021 17:15 ET | Neuronetics
MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...